Philipp Floersheim - Concepedia

Author

Philipp Floersheim

Novartis (Switzerland)

Also Known As

P Floersheim, P. FLOERSHEIM, P. Floersheim, Philipp Floersheim

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)University of Zurich Novartis Institutes for BioMedical Research

About

Philipp Floersheim is an author at Novartis (Switzerland) specializing in natural sciences, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	10	10	507
2	Medicine	9	9	426
3	Biochemistry	8	8	386
4	Engineering	1	1	34
5	Biology	1	1	69

Philipp Floersheim

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors Adriana Pagano, Doris Rüegg, Stephane Litschig, Journal of Biological Chemistry	2000	267
Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins Ansgar Schuffenhauer, Philipp Floersheim, Pierre Acklin, Journal of Chemical Information and Computer Sciences	2002	249
NMR Reporter Screening for the Detection of High-Affinity Ligands Wolfgang Jahnke, Philipp Floersheim, Christian Ostermeier, Angewandte Chemie International Edition Chemical BiologyGray SkeletonBiochemistryNatural SciencesMedicine	2002	98
Estrogen Receptor Modulators: Identification and Structure−Activity Relationships of Potent ERα-Selective Tetrahydroisoquinoline Ligands Johanne Renaud, Serge Bischoff, Thomas Buhl, Journal of Medicinal Chemistry High ThroughputPharmacotherapyPharmaceutical ChemistryMolecular PharmacologyMedicinal Chemistry	2003	88
Bisvertinols: a new group of dimeric vertinoids from Latchezar S. Trifonov, Hans Hilpert, Philipp Floersheim, Tetrahedron BiologyNatural SciencesNew GroupMolecular BiologyStereoselective Synthesis	1986	69
Selective Estrogen Receptor Modulators with Conformationally Restricted Side Chains. Synthesis and Structure−Activity Relationship of ERα-Selective Tetrahydroisoquinoline Ligands Johanne Renaud, Serge Bischoff, Thomas Buhl, Journal of Medicinal Chemistry	2004	65
Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABAB receptors Sébastien Guery, Philipp Floersheim, Klemens Kaupmann, Bioorganic & Medicinal Chemistry Letters Gabab ReceptorsMolecular PharmacologyNew Gs39783 AnaloguesBiochemistryG Protein-coupled Receptor	2007	62
Protection against ionising radiation and synergism with thiols by zinc aspartate G. L. Floersheim, Philipp Floersheim British Journal of Radiology	1986	46
Muscarinic activity of the thiolactone, lactam, lactol, and thiolactol analogs of pilocarpine and a hypothetical model for the binding of agonists to the M1 receptor Gideon Shapiro, Philipp Floersheim, Jakob Boelsterli, Journal of Medicinal Chemistry Thiolactone PilocarpineMuscarinic ActivityPharmacotherapyExperimental PharmacologyPharmaceutical Chemistry	1992	42
Chemogenomics knowledge-based strategies in drug discovery Edgar Jacoby, Ansgar Schuffenhauer, Philipp Floersheim Drug News & Perspectives Chemical BiologyDiscovery TechniqueSingular ObjectsDrug TargetNatural Sciences	2003	40

Page 1